Navigation Links
Researchers to Present Additional Data on Soliris(R) (eculizumab) for the Treatment of PNH at the ASH Annual Meeting
Date:11/10/2008

line publication.

-- "Efficacy of Eculizumab in a Plasmatherapy-Dependent Patient with

Atypical Hemolytic Uremic Syndrome with C3 mutation Following

Plasmatherapy Withdrawal," Dr Valerie Chatelet et al.

About Soliris

Soliris is the first product approved for the treatment of patients with PNH in the U.S. and Europe. PNH is a rare, debilitating and life-threatening blood disorder defined by the destruction of red blood cells, or hemolysis. In patients with PNH, hemolysis can cause life-threatening thromboses, recurrent pain, kidney disease, disabling fatigue, impaired quality of life, severe anemia, pulmonary hypertension, shortness of breath and intermittent episodes of dark-colored urine (hemoglobinuria). Soliris, or eculizumab, is the only treatment that blocks this hemolysis.

Important Safety Information

Soliris is generally well tolerated. The most frequent adverse events observed in clinical studies were headache, nasopharyngitis (a runny nose), back pain and nausea.

The U.S. product label for Soliris also includes a boxed warning: "Soliris increases the risk of meningococcal infections. Vaccinate patients with a meningococcal vaccine at least two weeks prior to receiving the first dose of Soliris; revaccinate according to current medical guidelines for vaccine use. Monitor patients for early signs of meningococcal infections, evaluate immediately if infection is suspected, and treat with antibiotics if necessary." During clinical studies, two out of 196 vaccinated PNH patients treated with Soliris experienced a serious meningococcal infection.

Please see full prescribing information at http://www.soliris.net.

About Alexion

Alexion Pharmaceuticals, Inc. is a biopharmaceutical company working to develop and deliver life-changing drug therapies for patients with serious and life-threatening medical conditions. The Company is
'/>"/>

SOURCE Alexion Pharmaceuticals, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine news :

1. USC researchers identify key mechanism that regulates the development of stem cells into neurons
2. Cornell researchers study showing evidence of a major environmental trigger for autism
3. Maastricht University researchers produce neural fingerprint of speech recognition
4. Researchers aim to over-stress already taxed mantle cell lymphoma cells
5. Researchers discover new risk factor for cardiovascular disease, and a way to control it
6. First Study of War-Related Mental Disorders Among Iraqis 10 Years Post-Gulf War Published by Researchers at Wayne State University and Basrah University, Iraq
7. Researchers find predictive tests and early treatment delay progression of blood cell cancer
8. Researchers describe how chronic inflammation can lead to stomach cancer
9. Researchers ID Genetic Markers for Esophageal Cancer
10. Researchers identify mechanism, possible drug treatment for tumors in neurofibromatosis
11. Cancer requires support from immune system to develop, UT Southwestern researchers report
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/31/2015)... On March 26, 2015, Vogue Magazine UK, in an ... a look into the trend of young women undergoing ... . The article suggests that celebrity endorsements (Beyoncé is cited ... Kardashian and Kylie Jenner are the drivers behind this trend. ... influences on the self-esteem of teenagers. (see: goo.gl/NmaB4q) , “I ...
(Date:3/31/2015)... 2015 Dr. Andrew Lian-Jie ... American Board of Dermatology and fellowship trained Mohs ... at the National Cancer Institute of the National ... in internal medicine at the Emory University and ... Philadelphia. Dr. Li pursued further training in Mohs ...
(Date:3/31/2015)... At Summit Breast Care, their passion is to provide ... caring manner. , Summit Breast Care has achieved national recognition ... cancer. They treat thousands of patients annually, not just ... Their doctors continue to be recognized as ‘Top Doctors’ ... Breast Care were planted in the mind and spirit of ...
(Date:3/31/2015)... 31, 2015 Researchers at UC ... and humans: how human livers heal. The difference ... liver regeneration. Normally, mouse PPARa is far more ... mice to quickly regenerate damaged livers. However, the ... (FGF21) can boost the regenerative effects of human ...
(Date:3/31/2015)... Former 49ers linebacker Chris Borland turned more heads with his ... promising NFL career. In a March episode of SCI ... explores the curious case of Borland and the potential ... process that Borland and other football players will likely use ... and what impact, if any, he thinks this case will ...
Breaking Medicine News(10 mins):Health News:Cosmetic Surgery: Does Social Media Pressure Young Girls to Get Botox and Fillers? 2Health News:Dr. Andrew Li of Warren Skin Care Center Is Celebrating 3 Years Recognized as an "NJ Top Doc" 2Health News:Summit Breast Care is Celebrating Four Years as "NJ Top Docs" 2Health News:UC Davis Study Finds Protein May Improve Liver Regeneration 2Health News:UC Davis Study Finds Protein May Improve Liver Regeneration 3Health News:UC Davis Study Finds Protein May Improve Liver Regeneration 4Health News:Will Leitch and the Curious Case of Chris Borland on SCI TV 2Health News:Will Leitch and the Curious Case of Chris Borland on SCI TV 3
... The anti-AIDS drug market is currently dominated by ... country's largest pharmaceutical company, is planning to enter ... director for India and west Asia, S D ... launch Lamivudine, Nevirapine, Aabacavir and Indinavir products in ...
... Complication as its other name. Among the many complications that ... ulcer, as damage can be severe enough to require amputation. ... in disguise would be a new device that delivers a ... stimulation would help in the healing of foot ulcers. ...
... procedure widely used on knees can also repair damaged ... best known for repairing knee injuries, but it is ... it is a minimally invasive surgical technique it is ... relieve different ankle problems, including ligament damage, bone chips ...
... techniques are being developed on a daily basis. One of ... those suffering from a degenerative eye condition. This degenerative condition ... fluid, causing scarring and loss of vision. ,Eye specialists ... Therapy, which has a lower risk rate of damaging the ...
... Paracetamol, whose active ingredient is Acetaminophen is found effective ... lowers body temperature in people who have had a ... Netherlands. ,Rise in the body temperature during the ... manifest as fever, has been linked to poorer outcomes ...
... pot of gold by making cheap anti-AIDS drugs. This ... escalate in coming days. ,The large number of ... drugs and market it in India and abroad by ... market, currently dominated by Mumbai-based Cipla, witnessed the entry ...
Cached Medicine News:Health News:Arthroscopy for Ankles 2
(Date:3/31/2015)... TAMPA, Fla. , March 31, 2015  Oxis ... biotech cancer therapy development and commercialization, announced today Oxis ... of the trading of Oxis common shares on the ... the OTCQB under the symbol OXIS.   ... "As Oxis continues to move forward with its strategies ...
(Date:3/31/2015)... MIAMI , March 31, 2015 ... TALOS™, today announced a strategic partnership with ... solutions for clinical research in life sciences. Offering ... global CRO has deployed Medidata,s electronic data capture ... support Biorasi,s Phase I through IV global clinical ...
(Date:3/31/2015)... , March 31, 2015  Ajinomoto Althea, Inc. ... development and manufacturing services, announced today that ... companies to its growing list of partners ... products using Althea,s Crystalomics ® ... total of 4 out of 10 of ...
Breaking Medicine Technology:Oxis International Inc. Announces Request for Euronext Trading Suspension 2Biorasi Selects Medidata's Cloud-Based Platform for Optimal Trial Operations 2Biorasi Selects Medidata's Cloud-Based Platform for Optimal Trial Operations 3Biorasi Selects Medidata's Cloud-Based Platform for Optimal Trial Operations 4Althea's New Drug Formulation Technology Gains Attention from Two More Top Pharmaceutical Companies 2
... , ENGLEWOOD, Colo., Dec. 7 ... DoseEdge(TM), during this week,s ASHP Midyear Clinical Meeting (MCM). ... safety and pharmacy efficiency through the management of IV ... into current pharmacy practice and techniques, while providing a ...
... , CARLSBAD, Calif., Dec. 7 Genoptix, Inc. (Nasdaq: ... the Company,s participation at the Deutsche Bank 2009 MedTools Investor ... Mass. on December 9-10, 2009. , Genoptix,s EVP ... the Company on Wednesday, December 9, 2009. He will ...
Cached Medicine Technology:Baxa Features DoseEdge(TM) Pharmacy Workflow Manager at the ASHP Midyear Clinical Meeting 2Baxa Features DoseEdge(TM) Pharmacy Workflow Manager at the ASHP Midyear Clinical Meeting 3Genoptix Announces Participation at Deutsche Bank 2009 MedTools Investor Conference 2
Fortitude as a unique complement to the spinal concepts family of products....
Caspar cervical retractor (lamina spreader), counter-retractor complete with 5 blades and forceps. Height: max. 165 mm, Maximal spread: 85 mm...
Cervical retractor with double finger hold, 3 depth 75 mm. Smooth...
Scoville cervical disc retractor, self-retaining with ratchet action....
Medicine Products: